BridgeMD
New treatment option for Idiopathic Ventricular Fibrillation
Official title MEdical Treatment in Idiopathic Ventricular Fibrillation Patients
ClinicalTrials.gov ID: NCT07405229
What this study is testing
What is Beta-blocker treatment group?
Beta-blocker treatment group is an investigational medicine, given as an once-daily, being studied as a potential treatment for idiopathic ventricular fibrillation.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- A person who has experienced a cardiac arrest with no apparent cause is at risk of having recurrent cardiac arrest. Hence an implantable cardioverter-defibrillator (ICD) is recommended on empirical grounds.
- Phase 4: studies an already-approved treatment
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Resuscitated OHCA patients admitted to one of the participating hospitals.
- Age ≥18 years
- Suspected cardiac cause of cardiac arrest
You likely can't join if
- OHCA patients
- With Ischemic heart disease.
- Obvious non-cardiac cause of cardiac arrest
- Congenital heart disease
- Do not speak or understand Danish
- Foreigners -
The study team makes the final eligibility decision.
Where it's taking place
- Copenhagen, Dr., Denmark
- Odense, Denmark
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Copenhagen, Dr., Denmark; Odense, Denmark. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.